Junli He - 11 Jan 2024 Form 4 Insider Report for Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Reporting relationship: CEO, Director
Issuer ticker: HRGN
Reported as of: 11 Jan 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Jan 2024, 20:09:59 UTC
Prior SEC filing: 03 Jan 2024
Next SEC filing: 02 Jul 2024
Source filing: View source filing
Reporting owner signature: /s/ Joseph Damasio, by power of attorney

Key filing fact

Junli He filed Form 4 for Harvard Apparatus Regenerative Technology, Inc. (HRGN) on 12 Jan 2024.

Key facts

This page summarizes Junli He's Form 4 filing for Harvard Apparatus Regenerative Technology, Inc. (HRGN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Jan 2024, 20:09.

Change

Previous filing in this sequence was filed on 03 Jan 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRGN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +220,640
Change %
Price: $0.000000
Shares after: 220,640
Date: 11 Jan 2024
Ownership: Direct
Underlying class: Common Stock, par value $0.01 per share
Underlying amount: 220,640
Exercise price: $4.07
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Subject to continued employment or service through the applicable vesting dates, up to 220,640 shall vest in two increments, each for 110,320 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer.